Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Corrections
\
May 12, page 10: A map in the article on forensic science incorrectly indicates that Maryland requires accreditation for forensic laboratories. Accreditation is optional. Maryland requires that forensic laboratories obtain and maintain a Maryland state license to perform services. These licensure requirements sometimes exceed forensic accreditation standards.
May 12, page 34: In a story on CDK 4/6-targeted cancer drug candidates, the structure of Eli Lilly & Co.’s bemaciclib is shown as a salt; it is being developed as the corresponding free base. The structure of Novartis’s LEE 011 is also incorrect. The correct structures are shown here.
Rudy Baum’s discourse on the solar rollout of spring was enjoyable to read (C&EN, May 5, page 3). But until we see photosynthesis lift a tree off the ground, propel it across the ocean, and land it at Heathrow Airport, fossil fuels will be tough to retire.
Chris Munkholm
Gloucester, Mass.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter